82 related articles for article (PubMed ID: 21894745)
1. [Nine-year experience in the treatment of patients with diffuse large B-cell lymphosarcoma].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EA; Bariakh EA; Mangasarova IaK; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Obukhova TN; Karagiulian SR; Shulutko EM; Galstian GM; Mar'in DS; Gabeeva NG; Vorob'ev AI
Ter Arkh; 2011; 83(7):5-10. PubMed ID: 21894745
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of conservative treatment of gastric lymphosarcoma].
Zvonkov EE; Kremenetskaia AM; Kravchenko SK; Makhinia VA; Kaplanskaia IB; Obukhova TN; Samoĭlova RS; Shevelev AA; Magomedova AU; Bariakh EA; Krasil'nikova BB; Gubkin AV; Iliushkina EA; Mar'in DS; Morozova AK; Kulikov SM; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2008; 80(7):18-26. PubMed ID: 18763589
[TBL] [Abstract][Full Text] [Related]
3. [First experience of using modified program NHL-BFM-90 for the treatment of primary diffuse large-B-cell lymphosarcoma of the bones and soft tissues with poor-prognosis].
Morozova AK; Zvonkov EE; Kremenetskaia AM; Magomedova AU; Obukhova TN; Mamonov VE; Bariakh EA; Gubkin AV; Lukina AI; Iliushkina EA; Fink OS; Perestoronina TN; Kravchenko SK
Ter Arkh; 2009; 81(7):61-5. PubMed ID: 19708576
[TBL] [Abstract][Full Text] [Related]
4. [International prognostic index in diffuse B large cell lymphosarcoma].
Magomedova AU; Vorob'ev AI
Ter Arkh; 2008; 80(3):71-6. PubMed ID: 18441690
[TBL] [Abstract][Full Text] [Related]
5. [Primary diffuse large B-cell lymphosarcoma of the spleen].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Kaplanskaia IB; Zybunova EE; Samoĭlova RS; Vorob'ev IA; Obukhova TN; Ryzhko VV; Zvonkov EE; Vorob'ev AI
Ter Arkh; 2007; 79(7):62-6. PubMed ID: 17802793
[TBL] [Abstract][Full Text] [Related]
6. [A CHOP-21 course efficacy in therapy of diffuse large B-cell lymphosarcoma].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Moiseeva TN; Zybunova EE; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Lorie IuIu; Margolin OV; Giliazitdinova EA; Gubkin AV; Chernova NG; Ryzhko VV; Gemdzhian EG
Ter Arkh; 2005; 77(7):58-61. PubMed ID: 16116911
[TBL] [Abstract][Full Text] [Related]
7. [The modified program NHL-BFM-90 in the treatment of patients with diffuse large B-cell lymphosarcoma].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Bariakh EA; Margolin OV; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Obukhova TN; Moiseeva TN; Zybunova EE; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2006; 78(10):44-7. PubMed ID: 17180937
[TBL] [Abstract][Full Text] [Related]
8. [First experience with the modified program NHL-BFM-90 application in adult patients with primary diffuse large B-cell gastric lymphosarcoma with unfavourable prognosis].
Zvonkov EE; Krasil'nikova BB; Makhinia VA; Kaplanskaia IB; Kravchenko SK; Karagiulian SR; Grzhimolovskiĭ AV; Kuznetsov AN; Magomedova AU; Shukhman IM; Bariakh EA; Giliazitdinova EA; Gubkin AV; Lorie IuIu; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):38-46. PubMed ID: 16944749
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
10. [Eight-year experience in treating aggressive mediastinal large B-cell lymphomas].
Mangasarova IaK; Magomedova AU; Kravchenko SK; Shmakov RG; Bariakh EA; Vorob'ev VI; Mar'in DS; Skidan NI; Gemdzhian ÉG; Misiurin AV; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2013; 85(7):50-6. PubMed ID: 24137947
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of a focal bone marrow lesion in diffuse large B-cell lymphosarcoma].
Magomedova AU; Kremenetskaia AM; Vorob'ev IA; Kravchenko SK; Kaplanskaia IB; Samoĭlova RS; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2004; 76(7):60-3. PubMed ID: 15379130
[TBL] [Abstract][Full Text] [Related]
12. [Primary lymphomas of bones and soft tissues: comparative assessment of treatment results].
Morozova AK; Zvonkov EE; Mamonov VE; Kremenetskaia AM; Kravchenko SK; Tseĭtlina MA; Stroiakovskiĭ DL; Bapiakh EA; Magomedova AU; Obukhova TN; Kaplanov KD; Pustovoĭt LA; Lukina AI; Gemdzhian ÉG; Egorova EK; Pen'kov MIu; Vorob'ev AI
Ter Arkh; 2012; 84(7):42-9. PubMed ID: 23038971
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.
Yoon DH; Choi DR; Ahn HJ; Kim S; Lee DH; Kim SW; Park BH; Yoon SO; Huh J; Lee SW; Suh C
Eur J Haematol; 2010 Aug; 85(2):149-57. PubMed ID: 20477862
[TBL] [Abstract][Full Text] [Related]
15. [Primary breast lymphoma--a report of 27 cases with literature review].
Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
18. Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.
Sar A; Perizzolo M; Stewart D; Mansoor A; Difrancesco LM; Demetrick DJ
Leuk Res; 2009 Jun; 33(6):792-7. PubMed ID: 19054557
[TBL] [Abstract][Full Text] [Related]
19. [Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma].
Dorokhina EI; Magomedova AU; Dvirnyk VN; Galtseva IV; Glinkina SA; Kulikov SM; Obukhova TN; Kravchenko SK
Ter Arkh; 2016; 88(7):43-48. PubMed ID: 27459614
[TBL] [Abstract][Full Text] [Related]
20. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ
J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
